Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2012	Oct. 01, 2011
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 309,405	$ (26,874)
Investing activities:
Capital expenditures	(29,162)	(56,085)
Disposition of business	12,708
Acquisition of business		(9,154)
Net cash used in investing activities	(16,454)	(65,239)
Financing activities:
Borrowings on notes payable	43,251	305,257
Repayments on notes payable	(55,645)	(322,185)
Borrowings on Accounts Receivable Securitization Facility	156,817	229,396
Repayments on Accounts Receivable Securitization Facility	(129,775)	(144,396)
Borrowings on Revolving Loan Facility	2,177,000	2,448,500
Repayments on Revolving Loan Facility	(2,191,500)	(2,433,500)
Redemption of Floating Rate Senior Notes	(148,092)
Proceeds from stock options exercised	4,103	16,784
Other	(2,348)	(2,364)
Net cash provided by (used in) financing activities	(146,189)	97,492
Effect of changes in foreign exchange rates on cash	162	(1,053)
Increase in cash and cash equivalents	146,924	4,326
Cash and cash equivalents at beginning of year	35,345	43,671
Cash and cash equivalents at end of period	182,269	47,997
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	531,201	377,231
Investing activities:
Capital expenditures	(6,107)	(11,234)
Net cash used in investing activities	(6,107)	(11,234)
Financing activities:
Borrowings on Revolving Loan Facility	2,177,000	2,448,500
Repayments on Revolving Loan Facility	(2,191,500)	(2,433,500)
Redemption of Floating Rate Senior Notes	(148,092)
Proceeds from stock options exercised	4,103	16,784
Other	(2,051)	(1,659)
Net transactions with related entities	(280,859)	(401,131)
Net cash provided by (used in) financing activities	(441,399)	(371,006)
Effect of changes in foreign exchange rates on cash	1
Increase in cash and cash equivalents	83,696	(5,009)
Cash and cash equivalents at beginning of year	8,330	17,535
Cash and cash equivalents at end of period	92,026	12,526
Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	116,698	131,185
Investing activities:
Capital expenditures	(5,147)	(8,084)
Net cash used in investing activities	(5,147)	(8,084)
Financing activities:
Net transactions with related entities	(111,248)	(123,085)
Net cash provided by (used in) financing activities	(111,248)	(123,085)
Increase in cash and cash equivalents	303	16
Cash and cash equivalents at beginning of year	2,726	2,039
Cash and cash equivalents at end of period	3,029	2,055
Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	53,477	(75,437)
Investing activities:
Capital expenditures	(17,908)	(36,767)
Disposition of business	12,708
Acquisition of business		(9,154)
Net cash used in investing activities	(5,200)	(45,921)
Financing activities:
Borrowings on notes payable	43,251	305,257
Repayments on notes payable	(55,645)	(322,185)
Borrowings on Accounts Receivable Securitization Facility	156,817	229,396
Repayments on Accounts Receivable Securitization Facility	(129,775)	(144,396)
Other	(297)	(705)
Net transactions with related entities	136	64,363
Net cash provided by (used in) financing activities	14,487	131,730
Effect of changes in foreign exchange rates on cash	161	(1,053)
Increase in cash and cash equivalents	62,925	9,319
Cash and cash equivalents at beginning of year	24,289	24,097
Cash and cash equivalents at end of period	87,214	33,416
Consolidation, Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(391,971)	(459,853)
Financing activities:
Net transactions with related entities	391,971	459,853
Net cash provided by (used in) financing activities	$ 391,971	$ 459,853